CAS: 50606-32-1; Butyl Piperazine-1-Carboxylate

该化合物是一种有机化合物,其特点是其管子环结构,这是一个六人环状环状矿,含有两个氮原子;该化合物的特点是与一个丁基体组一起受精的碳盒酸功能组,该组有助于溶解性和再活性;该产品一般是无色的,可粉黄,具有中度沸点,在有机溶剂中可溶解;管子酸的存在具有基本特性,使其与各种生物系统互动,使其对医药化学感兴趣.此外,丁基酯组可增强其亲脂性,从而影响其药用动力特性.该化合物可用于合成药物或有机合成的中间体.应参考安全数据处理,因为如果摄入或吸入,可能会对健康造成危害.总体而言,1-全氟辛烷磺酸箱酸,丁酯是一种多种特性,可在各种化学和制药环境中应用.

结构式图片

相似化合物

120-43-4 37038-26-9 2138149-55-8

上下游产品

CAS号1019928-96-1 4-benzyl-pipera... | CAS号1073554-07-0 piperazine-1,4-... | CAS号110-85-0 哌嗪 | CAS号592-34-7 氯甲酸正丁酯

合成工艺路线路线简述

  • 合成目标产物 N-(N-Butoxycarbonyl)Piperazine 主要起始原料 1,4-Piperazinedicarboxylic Acid, 1-Butyl 4-(1,1-Dimethylethyl) Ester
  • (文献来源)合成步骤主要原料 1,4-Piperazinedicarboxylic Acid, 1-Butyl 4-(1,1-Dimethylethyl) Ester
📜氯甲酸丁酯置于palladium On Activated Charcoal,氢气,三乙胺体系中,用 乙醇,二氯甲烷 作为反应溶剂,化学反应生成 丁基哌嗪-1-羧酸
参考文献:Optimization Of 2-Phenyl-Pyrimidine-4-Carboxamides Towards Potent,Orally Bioavailable And Selective P2Y12 Antagonists For Inhibition Of Platelet Aggregation
标题:Optimization Of 2-Phenyl-Pyrimidine-4-Carboxamides Towards Potent,Orally Bioavailable And Selective P2Y12 Antagonists For Inhibition Of Platelet Aggregation
摘要:2-Phenyl-Pyrimidine-4-Carboxamide Analogs Were Identified As P2Y12 Antagonists. Optimization Of The Carbon-Linked Or Nitrogen-Linked Substituent At The 6-Position Of The Pyrimidine Ring Provided Compounds With Excellent Ex Vivo Potency In The Platelet Aggregation Assay In Human Plasma. Compound 23U Met The Objectives For Activity,Selectivity And Admet Properties.
DOI:10.1016/j.Bmcl.2014.06.070

海关参考信息

专利信息


专利号:US-2024317784-A1
优先权日:2021-07-13
标题 :Process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester
发明人:BLUMER NICOLE; CLAVEAU ROMAIN; FEYEN FABIAN; HALL LEANNE; HUGHES STEPHEN; REBER STEFAN
权利人:VIATRIS ASIA PACIFIC PTE LTD
摘要:The present invention relates to a process for the synthesis of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester, or of a hydrochloride salt thereof; and to a crystalline form of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester hydrochloride.

专利号:WO-2014191548-A1
优先权日:2013-05-31
标题:New process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine
发明人:ZUPANCIC BORUT
权利人:LEK PHARMACEUTICALS
摘要:The present invention provides a new synthetic process for the production of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine (vortioxetine), an experimental drug under development for the treatment of depression and anxiety, which comprises the reaction of a compound of formula (VII), or salt thereof, (VII) wherein Q represents S, SO or SO 2 and LG represents a leaving group, with a compound of formula (XI), or salt thereof, (XI) wherein Z represents hydrogen or a protecting group. New intermediate compounds are also provided.

专利号:US-9284344-B2
优先权日:2012-05-30
标题:Oligonucleotide synthesis method using highly dispersible liquid-phase support
发明人:KIM SHOKAKU; MATSUMOTO MASANORI
权利人:KIM SHOKAKU; MATSUMOTO MASANORI; HOKKAIDO SYSTEM SCIENCE CO LTD
摘要:A nucleic acid synthesis method enabling a reaction in a fluid (flow) with a highly dispersible liquid-phase support to improve coupling efficiency is provided. n The method for synthesizing an oligonucleotide comprising: sequentially condensing and oxidizing a nucleoside phosphoramidite compound in the presence of an acid/azole complex compound using a starting raw material, i.e., hydrophobic group-bonded nucleoside represented by Formula (1): n where R 1 : an alkylene group having 1 to 12 carbon atoms, R 2 : an alkylene group having 1 to 22 carbon atoms, R 3 and R 4 each independently represent an alkyl group having 1 to 22 carbon atoms or the like, R 5 : a single bond or an alkylene group having 1 to 22 carbon atoms, R 6 : each independently an alkyl group having 6 to 30 carbon atoms, n represents an integer of 2 to 6, X represents a hydrogen atom, hydroxyl group, or the like, Y: a protecting group deprotectable under an acidic condition, and Z: an adenyl group, a guanyl group, or the like having a polar group optionally protected by a protecting group,n wherein a condensation reaction is performed by preliminarily dissolving the hydrophobic group-bonded nucleoside or hydrophobic group-bonded oligonucleotide and the nucleoside phosphoramidite compound in a non-polar solvent, and contacting the resulting solution with the acid/azole complex compound or a solution containing the complex compound.

专利号:WO-2023285342-A2
优先权日:2021-07-13
标题 :A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester

专利号:EP-4370525-A2
优先权日:2021-07-13
标 题 :A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester

专利号:EP-1280780-A2
优先权日:2000-05-04
标 题:Asymmetric synthesis of piperazic acid and derivatives thereof

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s11746-006-1248-1
摘要:Zerkowski JA, Solaiman DKY. Synthesis of polyfunctional fatty amines from sophorolipid‐derived 17‐hydroxy oleic acid. J Americ Oil Chem Soc. 2006 Jul;83(7):621–8. doi: 10.1007/s11746-006-1248-1.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知